Treatment of Chronic Hepatitis with Sofosbuvir in Combination with Ribavirin with or without Pegylated Interferon

被引：0
|
作者：
Sidhu, Sandeep S. [1 ]
Malhi, Nirmaljeet [2 ]
Singh, Rupinder [3 ]
Gover, Rajiv [4 ]
Sidhu, Js [5 ]
Bansal, Ajesh [6 ]
Goyal, Omesh [1 ]
Sidhu, Gursewak [3 ]
Nanda, Vijay [7 ]
Saluja, Harmeet [2 ]
Sehgal, Alok [8 ]
Simran, Sidhu [9 ]
Kishore, Harsh [1 ]
机构：
[1] Dayanand Med Coll & Hosp, Ludhiana, Punjab, India
[2] Satguru Partap Singh Apollo Hosp, Ludhiana, Punjab, India
[3] Malwa Hosp, Bathinda, Punjab, India
[4] AIMS Bassi Hosp, Ludhiana, Punjab, India
[5] Parvati Hosp, Amritsar, Punjab, India
[6] Delhi Heart Inst & Multispecial Hosp, Bathinda, Punjab, India
[7] Kidney Hosp, Jalandher, Punjab, India
[8] Patel Hosp Specialty, Ludhiana, Punjab, India
[9] Himalayan Inst Med Sci, Ludhiana, Punjab, India
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2016年 / 111卷
关键词：
D O I：
10.14309/00000434-201610001-00875
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
875
引用
收藏
页码：S383 / S383
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of sofosbuvir plus ribavirin with or without pegylated interferon for the treatment of chronic hepatitis C in Italy
    Cure, Sandrine
    Guerra, Ines
    Camma, Calogero
    Craxi, Antonio
    Carosi, Giampiero
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (09) : 678 - 690
  • [2] Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2
    Seo, Kayo
    Kim, Soo Ki
    Kim, Soo Ryang
    Ohtani, Aya
    Kobayashi, Mana
    Kato, Airi
    Morimoto, Eri
    Saijo, Yuka
    Kim, Ke Ih
    Imoto, Susumu
    Kim, Chi Wan
    Yano, Yoshihiko
    Kudo, Masatoshi
    Hayashi, Yoshitake
    [J]. DIGESTIVE DISEASES, 2017, 35 (06) : 541 - 547
  • [3] Pegylated Interferon and Ribavirin for the Treatment of Chronic Hepatitis C
    Kemp, William
    Roberts, Stuart
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 137 - 150
  • [4] Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
    Aizawa, Nobuhiro
    Enomoto, Hirayuki
    Takashima, Tomoyuki
    Sakai, Yoshiyuki
    Iwata, Kazunari
    Ikeda, Naoto
    Tanaka, Hironori
    Iwata, Yoshinori
    Saito, Masaki
    Imanishi, Hiroyasu
    Iijima, Hiroko
    Nishiguchi, Shuhei
    [J]. JOURNAL OF GASTROENTEROLOGY, 2014, 49 (08) : 1253 - 1263
  • [5] Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
    Nobuhiro Aizawa
    Hirayuki Enomoto
    Tomoyuki Takashima
    Yoshiyuki Sakai
    Kazunari Iwata
    Naoto Ikeda
    Hironori Tanaka
    Yoshinori Iwata
    Masaki Saito
    Hiroyasu Imanishi
    Hiroko Iijima
    Shuhei Nishiguchi
    [J]. Journal of Gastroenterology, 2014, 49 : 1253 - 1263
  • [6] Chronic hepatitis C: Treatment of pegylated interferon/ribavirin nonresponders
    Shiffman M.L.
    [J]. Current Gastroenterology Reports, 2006, 8 (1) : 46 - 52
  • [7] Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
    Carvalho-Filho, Roberto J.
    Dalgard, Olav
    [J]. PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2010, 3 : 1 - 13
  • [8] Chronic hepatitis C: Treatment of pegylated interferon/ribavirin nonresponders
    Shiffman M.L.
    [J]. Current Hepatitis Reports, 2006, 5 (3) : 114 - 120
  • [9] Treatment of chronic hepatitis C with PEGylated interferon and ribavirin.
    Cornberg M.
    Wedemeyer H.
    Manns M.P.
    [J]. Current Gastroenterology Reports, 2002, 4 (1) : 23 - 30
  • [10] Comparison of combination therapy of pegylated interferon and ribavirin with conventional interferon and ribavirin in chronic hepatitis C in Korea
    Kang, Myoung Joo
    Jung, Eun Uk
    Park, Sang Won
    Choi, Paul
    Kim, Ji Hyun
    Park, Sung Jae
    Park, Eun Taek
    Lee, Youn Jae
    Lee, Sang Hyuk
    Seol, Sang Yong
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A217 - A217
12345